000 -LEADER |
fixed length control field |
01605cam a22003494a 4500 |
001 - CONTROL NUMBER |
control field |
16217553 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OSt |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20141025165820.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
100503s2010 nyua b 001 0 eng |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780071627290 (pbk. : alk. paper) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
0071627294 (pbk. : alk. paper) |
040 ## - CATALOGING SOURCE |
Transcribing agency |
SA-DiMC |
050 10 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RM301.13 |
Item number |
.Y68 2010 |
060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
QV 18.2 |
Item number |
G554d 2010 |
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.1076 |
Edition number |
22 |
Item number |
DEG |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Gleason, Jessica A. |
245 10 - TITLE STATEMENT |
Title |
Deja review. |
Name of part/section of a work |
Pharmacology / |
Statement of responsibility, etc. |
Jessica A. Gleason. |
246 13 - VARYING FORM OF TITLE |
Title proper/short title |
Pharmacology |
250 ## - EDITION STATEMENT |
Edition statement |
2nd ed. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc. |
New York : |
Name of publisher, distributor, etc. |
McGraw-Hill Medical, |
Date of publication, distribution, etc. |
c2010. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xiv, 219 p. : |
Other physical details |
ill. ; |
Dimensions |
23 cm. |
490 1# - SERIES STATEMENT |
Series statement |
Déjà review |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc |
Includes bibliographical references and index. |
505 8# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Machine generated contents note: Ch. 1. General Principles -- Ch. 2. Anti-Neoplastic Agents -- Ch. 3. Anti-Bacterial Agents -- Ch. 4. Anti-Fungal Agents -- Ch. 5. Anti-Viral Agents -- Ch. 6. Anti-Protozoal Agents -- Ch. 7. Anti-Helminthic Agents -- Ch. 8. Autonomic Agents -- Ch. 9. CNS Agents -- Ch. 10. Cardiovascular/Renal Agents -- Ch. 11. Pulmonary Agents -- Ch. 12. Gastrointestinal Agents -- Ch. 13. Endocrine Agents -- Ch. 14. Anti-Inflammatory Agents -- Ch. 15. Biologic Agents -- Suggested Readings -- Index. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Pharmacology |
Form subdivision |
Examinations, questions, etc. |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Pharmacological Phenomena |
Form subdivision |
Examination Questions. |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Drug Therapy |
Form subdivision |
Examination Questions. |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Pharmaceutical Preparations |
Form subdivision |
Examination Questions. |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
Uniform title |
Deja review. |
901 ## - LOCAL DATA ELEMENT A, LDA (RLIN) |
a |
353 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
|
Koha item type |
Books |